Martin Kjellberg
Martin Kjellberg has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
- Aimé Lumaka
Center for Human Genetics, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo
1 shared publication - Alain Verloes
Dept of Genetics, Assistance Publique-Hôpitaux de Paris, Université de Paris, Robert DEBRE University Hospital, Paris, France
1 shared publication Alassane Baneye Maiga
Faculté de Medecine et d’OdontoStomatologie, Université des Sciences, des Techniques et des Technologies de Bamako, Bamako, Mali
1 shared publication- Anders Jemt
Clinical Genomics Stockholm, Science for Life Laboratory, Department of Microbiology, Tumor & Cell Biology, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Angelica Maria Delgado-Vega
Department of Clinical Genetics and Genomics, Karolinska University Hospital, 17164 Stockholm, Sweden
1 shared publication - Ann Nordgren
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
1 shared publication
Latest Publications
- Open Access
- 1 August 2026
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 19 (4) , e005341
Machine Learning Reveals the Contribution of Rare Genetic Variants and Enhances Risk Prediction for Coronary Artery Disease in the Japanese Population
BACKGROUND: GWASs (genome-wide association studies) have advanced our understanding of coronary artery disease (CAD) genetics and enabled the development of polygenic risk scores (PRSs) for estimating genetic risk based on common variant burden. However, GWASs have limitations in analyzing rare variants due to insufficient statistical power, thereby constraining PRS performance. METHODS: We conducted whole-genome sequencing of 1752 Japanese patients with CAD and 3019 controls. A machine learning-based analytical framework was applied to identify and interpret rare genetic variants associated with CAD pathogenesis. RESULTS: This approach identified 59 CAD-related genes, including known causal genes such as LDLR and those not previously captured by GWASs. A rare variant-based risk score derived from the framework demonstrated distinct clinical characteristics compared with a conventional common variant-based PRS. The rare variant-based risk score significantly discriminated CAD cases and predicted cardiovascular mortality in an independent cohort. Furthermore, combining the rare variant-based risk score with the traditional PRS improved CAD prediction compared with the PRS alone (area under the curve, 0.66 versus 0.61; P =0.007). CONCLUSIONS: These findings underscore the distinct and complementary value of the rare variant-based risk score compared with the conventional PRS, highlighting the enhanced predictive power achieved through their integration. This comprehensive approach proposes broader genetic profiling, offering substantial potential for improved clinical risk stratification and personalized prevention strategies.
- 1 August 2026
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 19 (4) , e005341
Open AccessMachine Learning Reveals the Contribution of Rare Genetic Variants and Enhances Risk Prediction for Coronary Artery Disease in the Japanese Population
BACKGROUND: GWASs (genome-wide association studies) have advanced our understanding of coronary artery disease (CAD) genetics and enabled the development of polygenic risk scores (PRSs) for estimating genetic risk based on common variant burden. However, GWASs have limitations in analyzing rare variants due to insufficient statistical power, thereby constraining PRS performance. METHODS: We conducted whole-genome sequencing of 1752 Japanese patients with CAD and 3019 controls. A machine learning-based analytical framework was applied to identify and interpret rare genetic variants associated with CAD pathogenesis. RESULTS: This approach identified 59 CAD-related genes, including known causal genes such as LDLR and those not previously captured by GWASs. A rare variant-based risk score derived from the framework demonstrated distinct clinical characteristics compared with a conventional common variant-based PRS. The rare variant-based risk score significantly discriminated CAD cases and predicted cardiovascular mortality in an independent cohort. Furthermore, combining the rare variant-based risk score with the traditional PRS improved CAD prediction compared with the PRS alone (area under the curve, 0.66 versus 0.61; P =0.007). CONCLUSIONS: These findings underscore the distinct and complementary value of the rare variant-based risk score compared with the conventional PRS, highlighting the enhanced predictive power achieved through their integration. This comprehensive approach proposes broader genetic profiling, offering substantial potential for improved clinical risk stratification and personalized prevention strategies.
- 21 October 2024
- Published by Springer Nature in Nature Genetics
- Vol. 56 (11) , 2287-2294
Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon
In the first-ever Undiagnosed Hackathon, nearly 100 experts from 28 countries combined advanced phenotyping and genomic techniques for 48 hours, ultimately providing diagnoses to 40% of the previously undiagnosed families. This inspiring model demonstrates the power of multidisciplinary collaboration and patient partnership in precision diagnostics.
- 21 October 2024
- Published by Springer Nature in Nature Genetics
- Vol. 56 (11) , 2287-2294
Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon
In the first-ever Undiagnosed Hackathon, nearly 100 experts from 28 countries combined advanced phenotyping and genomic techniques for 48 hours, ultimately providing diagnoses to 40% of the previously undiagnosed families. This inspiring model demonstrates the power of multidisciplinary collaboration and patient partnership in precision diagnostics.